FDA panel endorses booster for single-shot vaccine

A panel of U.S. health advisers has endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine. The FDA panel said Friday that the booster should be offered at least two months after immunization but didn't suggest a firm time. (Oct. 15)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting